MOA Life Plus Co. Ltd. (KOSDAQ:142760)
South Korea · Delayed Price · Currency is KRW 870.00
-24.00 (-2.68%)
At close: Apr 28, 2026
MOA Life Plus Market Cap
MOA Life Plus has a market cap or net worth of 36.69 billion as of April 28, 2026. Its market cap has decreased by -25.04% in one year.
Market Cap
36.69B
Enterprise Value
35.04B
Revenue
11.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
870.00
Market Cap Chart
Since July 7, 2016, MOA Life Plus's market cap has decreased from 97.39B to 36.69B, a decrease of -62.33%. That is a compound annual growth rate of -9.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 36.69B | -47.08% |
| Dec 30, 2025 | 69.32B | 51.95% |
| Dec 30, 2024 | 45.62B | -33.64% |
| Dec 28, 2023 | 68.75B | -38.77% |
| Dec 29, 2022 | 112.27B | -53.08% |
| Dec 30, 2021 | 239.30B | 38.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Sciences | 64.81B |
| EyeGene | 62.55B |
| ADBiotech | 53.33B |
| J2KBIO | 50.11B |
| NGeneBio | 45.23B |
| Parataxis Korea | 44.13B |
| SCM Lifescience | 40.98B |
| Kainos Medicine | 35.56B |